Reuters Stock Buzz Powered by SocialPicks Logo_divider Logo_thomsonreuters Bg_dots_d1
   Sign Up   |   Log In   |   What is Reuters Stock Buzz?   |   FAQ powered by Logo_powered_by_socialpicks

Important Message: The Reuters Stock Buzz beta period will end Friday, October 31. If you would like to continue to access your Stock Buzz account through SocialPicks, please click here

 Repligen Corp.  (RGEN)     Rate RGEN  -  Discuss RGEN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate RGEN:



RGEN: Bull or Bear?

Pict0062
-14.34%
 risk: low
biopharmaceutical lottery ticket  01/22/08
Repligen has potential in its pipeline with RG2417 (Oral Bipolar treatment) and RG1068 (Aids in MRI imaging of the pancreas). RG1068 is closer to FDA approval and RG2417 is not far behind. FDA approval will skyrocket the price. Company also has lots of cash on hand, always good in a small company.




People Bullish on RGEN

Acarbuff
mr.haney
Associate
73%
2 days ago

Frostyball
elnino
Analyst
61%
6 mos ago

Pict0062
Drew
Analyst
30%
8 mos ago

razrbak
Sr. Analyst
72%
9 mos ago

Kirk W
Analyst
39%
11 mos ago


People Bearish on RGEN

 


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Repligen Corp. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters